Companies inform investors of possible business risks from Trump's government changes, tucking warnings into extensive "risk ...

CVS Health (CVS) has made an impressive comeback in 2025, with its stock soaring 45% so far this year. This sharp rebound ...

CVS CEO David Joyner just finished his first full quarter at the helm. He spoke with Yahoo Finance about the conservative ...

CVS Health reported $1.6 billion in profit for the fourth quarter, down from a $2 billion haul a year ago, according to its ...

Companies are telling their investors how President Donald Trump’s plan to radically remake the US government poses new risks ...

CVS CEO David Joyner’s comments come as lawmakers on both sides of the aisle and President Donald Trump have signaled ...

CVS Health has named Ed DeVaney as president of its pharmacy benefit manager, CVS Caremark. | DeVaney has served as interim ...

CVS Health CEO David Joyner sees a way to create a more efficient healthcare professional network under the CVS umbrella.

Just as Andrew Witty of UnitedHealth Group did in a call with investors last month, CVS Health’s CEO David Joyner defended ...

Our drive to greater drug pricing transparency through innovation has never been more needed,” Ed DeVaney says.

The high cost of sickle cell gene therapies is pushing private insurers and Medicaid programs to develop new payment models.